Amundi

Amundi Portfolio holdings

AUM $290B
1-Year Return 20.97%
 

Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.

This Quarter Return
+9.24%
1 Year Return
+20.97%
3 Year Return
+97.23%
5 Year Return
10 Year Return
AUM
$144B
AUM Growth
Cap. Flow
+$144B
Cap. Flow %
99.75%
Top 10 Hldgs %
21.67%
Holding
1,481
New
1,418
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Technology 24.94%
2 Healthcare 13.45%
3 Consumer Discretionary 13.21%
4 Financials 12.8%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
APPN icon
1326
Appian
APPN
$2.2B
$193K ﹤0.01%
+1,400
New +$193K
PLCE icon
1327
Children's Place
PLCE
$113M
$192K ﹤0.01%
+2,058
New +$192K
AXSM icon
1328
Axsome Therapeutics
AXSM
$6.11B
$189K ﹤0.01%
+2,800
New +$189K
III icon
1329
Information Services Group
III
$250M
$188K ﹤0.01%
+32,161
New +$188K
KNSL icon
1330
Kinsale Capital Group
KNSL
$10.6B
$188K ﹤0.01%
+1,139
New +$188K
INVA icon
1331
Innoviva
INVA
$1.32B
$187K ﹤0.01%
+13,946
New +$187K
AGYS icon
1332
Agilysys
AGYS
$2.95B
$186K ﹤0.01%
+3,267
New +$186K
ATRA icon
1333
Atara Biotherapeutics
ATRA
$88.3M
$185K ﹤0.01%
+477
New +$185K
VIR icon
1334
Vir Biotechnology
VIR
$752M
$182K ﹤0.01%
+3,842
New +$182K
PCH icon
1335
PotlatchDeltic
PCH
$3.19B
$181K ﹤0.01%
+3,398
New +$181K
TRIP icon
1336
TripAdvisor
TRIP
$2.02B
$181K ﹤0.01%
+4,498
New +$181K
ZUMZ icon
1337
Zumiez
ZUMZ
$318M
$181K ﹤0.01%
+3,685
New +$181K
USCR
1338
DELISTED
U S Concrete, Inc.
USCR
$181K ﹤0.01%
+2,453
New +$181K
AGIO icon
1339
Agios Pharmaceuticals
AGIO
$2.01B
$180K ﹤0.01%
+3,264
New +$180K
KTOS icon
1340
Kratos Defense & Security Solutions
KTOS
$10.6B
$179K ﹤0.01%
+6,288
New +$179K
QLYS icon
1341
Qualys
QLYS
$4.83B
$178K ﹤0.01%
+1,764
New +$178K
STOK icon
1342
Stoke Therapeutics
STOK
$1.04B
$178K ﹤0.01%
+5,300
New +$178K
VECO icon
1343
Veeco
VECO
$1.42B
$177K ﹤0.01%
+7,351
New +$177K
ALRM icon
1344
Alarm.com
ALRM
$2.81B
$176K ﹤0.01%
+2,081
New +$176K
TREE icon
1345
LendingTree
TREE
$938M
$176K ﹤0.01%
+829
New +$176K
TRHC
1346
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$174K ﹤0.01%
+3,481
New +$174K
WERN icon
1347
Werner Enterprises
WERN
$1.68B
$173K ﹤0.01%
+3,877
New +$173K
PSMT icon
1348
Pricesmart
PSMT
$3.34B
$172K ﹤0.01%
+1,891
New +$172K
DMTK
1349
DELISTED
DermTech, Inc. Common Stock
DMTK
$172K ﹤0.01%
+4,128
New +$172K
KRTX
1350
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$172K ﹤0.01%
+1,513
New +$172K